Duke St. John's Wort Study Findings Imminent - NCCAM's Straus
This article was originally published in The Tan Sheet
Executive Summary
Results of a National Institutes of Health-funded study on the active constituent of St. John's wort's efficacy in treating depression are due shortly, according to National Center for Complementary & Alternative Medicine Director Stephen Straus, MD.
You may also be interested in...
St. John's Wort Prior Study Limitations Stressed In JAMA Research
Previous studies of St. John's wort have had numerous flaws - such as small sample sizes and low doses - a recent study led by Richard Shelton, MD, Vanderbilt University, et al., states.
St. John's Wort Prior Study Limitations Stressed In JAMA Research
Previous studies of St. John's wort have had numerous flaws - such as small sample sizes and low doses - a recent study led by Richard Shelton, MD, Vanderbilt University, et al., states.
St. John's Wort Prior Study Limitations Stressed In JAMA Research
Previous studies of St. John's wort have had numerous flaws - such as small sample sizes and low doses - a recent study led by Richard Shelton, MD, Vanderbilt University, et al., states.